These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 29192476

  • 1. Melanonychia induced by venlafaxine hydrochloride.
    Mercuri SR, Paolino G, Mavilia L, Didona D, Brianti P.
    G Ital Dermatol Venereol; 2019 Aug; 154(4):495-496. PubMed ID: 29192476
    [No Abstract] [Full Text] [Related]

  • 2. Delayed Sinus Tachycardia Associated With Venlafaxine Administration: A Unique Case Report and Discussion.
    Osuagwu FC, Bradley R.
    J Clin Psychopharmacol; 2019 Aug; 39(6):689-690. PubMed ID: 31688406
    [No Abstract] [Full Text] [Related]

  • 3. Venlafaxine induced QTc interval prolongation in a therapeutic dose.
    Bavle A.
    Asian J Psychiatr; 2015 Aug; 16():63-4. PubMed ID: 26187237
    [Abstract] [Full Text] [Related]

  • 4. Seizure Induced by a Therapeutic Dose of Venlafaxine ER: A Case Report.
    Ye C, Ninneman M, Christian JS, Zhang F, Musselman D.
    J Psychiatr Pract; 2018 Mar; 24(2):117-120. PubMed ID: 29509182
    [Abstract] [Full Text] [Related]

  • 5. Venlafaxine induced akathisia: a case report.
    Ceylan ME, Evrensel A.
    Trends Psychiatry Psychother; 2016 Mar; 38(2):117. PubMed ID: 27409139
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
    Lassen D, Ennis ZN, Damkier P.
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
    [Abstract] [Full Text] [Related]

  • 8. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
    Bellantuono C, Vargas M, Mandarelli G, Nardi B, Martini MG.
    Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serotonin syndrome, rhabdomyolysis and convulsion associated with drug interaction between venlafaxine and amoxicillin/clavulanic acid.
    Fernández-Ferreiro A, Pose-Reino A, Martinez-Bahamonde F, Paris M, Guemas E, González-Barcia M, Lamas MJ.
    Actas Esp Psiquiatr; 2016 Sep; 44(5):193-202. PubMed ID: 27644102
    [No Abstract] [Full Text] [Related]

  • 11. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
    Cutler N.
    Prim Care Companion CNS Disord; 2017 Feb 09; 19(1):. PubMed ID: 28196312
    [No Abstract] [Full Text] [Related]

  • 12. Venlafaxine-Associated Euprolactinemic Galactorrhea and Hypersexuality: A Case Report and Review of the Literature.
    Warren MB.
    J Clin Psychopharmacol; 2016 Aug 09; 36(4):399-400. PubMed ID: 27219091
    [No Abstract] [Full Text] [Related]

  • 13. Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.
    Volon B, Willemart T, Haufroid V, Hantson P.
    Prim Care Companion CNS Disord; 2019 Nov 27; 21(6):. PubMed ID: 31794166
    [No Abstract] [Full Text] [Related]

  • 14. Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults.
    Wathra R, Mulsant BH, Thomson L, Goldberger KW, Lenze EJ, Karp JF, Sanches M, Reynolds CF, Blumberger DM.
    J Psychopharmacol; 2020 Oct 27; 34(10):1112-1118. PubMed ID: 32842836
    [Abstract] [Full Text] [Related]

  • 15. Apathy symptoms induced by low-dose venlafaxine: Two cases.
    Sato S, Sodeyama N, Matsuzaki A, Shiratori Y.
    Neuropsychopharmacol Rep; 2020 Jun 27; 40(2):196-197. PubMed ID: 32267090
    [Abstract] [Full Text] [Related]

  • 16. Rhabdomyolysis With Acute Renal Failure Requiring Dialysis in McArdle Disease: A Role for the Antidepressant Venlafaxine?
    Torner S, Tinel C, Soltani Z, Rifle G, Mousson C.
    J Clin Psychopharmacol; 2016 Aug 27; 36(4):406-8. PubMed ID: 27300253
    [No Abstract] [Full Text] [Related]

  • 17. How Does Usage of Serotonin Noradrenaline Reuptake Inhibitors Affect Intraocular Pressure in Depression Patients?
    Uçan Gündüz G, Parmak Yener N, Kılınçel O, Gündüz C.
    J Ocul Pharmacol Ther; 2018 May 27; 34(4):354-359. PubMed ID: 29446702
    [Abstract] [Full Text] [Related]

  • 18. Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder.
    Ozbey G, Celikel FC, Cumurcu BE, Kan D, Yucel B, Hasbek E, Percin F, Guzey IC, Uluoglu C.
    Nord J Psychiatry; 2017 Apr 27; 71(3):230-237. PubMed ID: 28079463
    [Abstract] [Full Text] [Related]

  • 19. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.
    Selmer R, Haglund B, Furu K, Andersen M, Nørgaard M, Zoëga H, Kieler H.
    Pharmacoepidemiol Drug Saf; 2016 Oct 27; 25(10):1160-1169. PubMed ID: 27193296
    [Abstract] [Full Text] [Related]

  • 20. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
    Islin J, Munkboel CH, Styrishave B.
    Toxicol In Vitro; 2018 Mar 27; 47():63-71. PubMed ID: 29100959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.